Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth
A promising new strategy for cancer therapy is to target the autophagic pathway. In the current study, we demonstrate that the antimalarial drug Quinacrine (QC) reduces cell viability and promotes chemotherapy-induced cell death in an autophagy-dependent manner more extensively in chemoresistant cel...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742182/ https://www.ncbi.nlm.nih.gov/pubmed/26497553 |
_version_ | 1782414159241019392 |
---|---|
author | Khurana, Ashwani Roy, Debarshi Kalogera, Eleftheria Mondal, Susmita Wen, Xuyang He, Xiaoping Dowdy, Sean Shridhar, Viji |
author_facet | Khurana, Ashwani Roy, Debarshi Kalogera, Eleftheria Mondal, Susmita Wen, Xuyang He, Xiaoping Dowdy, Sean Shridhar, Viji |
author_sort | Khurana, Ashwani |
collection | PubMed |
description | A promising new strategy for cancer therapy is to target the autophagic pathway. In the current study, we demonstrate that the antimalarial drug Quinacrine (QC) reduces cell viability and promotes chemotherapy-induced cell death in an autophagy-dependent manner more extensively in chemoresistant cells compared to their isogenic chemosensitive control cells as quantified by the Chou-Talalay methodology. Our preliminary data, in vitro and in vivo, indicate that QC induces autophagy by downregulating p62/SQSTM1 to sensitize chemoresistant cells to autophagic- and caspase-mediated cell death in a p53-independent manner. QC promotes autophagosome accumulation and enhances autophagic flux by clearance of p62 in chemoresistant ovarain cancer (OvCa) cell lines to a greater extent compared to their chemosensitive controls. Notably, p62 levels were elevated in chemoresistant OvCa cell lines and knockdown of p62 in these cells resulted in a greater response to QC treatment. Bafilomycin A, an autophagy inhibitor, restored p62 levels and reversed QC-mediated cell death and thus chemosensitization. Importantly, our in vivo data shows that QC alone and in combination with carboplatin suppresses tumor growth and ascites in the highly chemoresistant HeyA8MDR OvCa model compared to carboplatin treatment alone. Collectively, our preclinical data suggest that QC in combination with carboplatin can be an effective treatment for patients with chemoresistant OvCa. |
format | Online Article Text |
id | pubmed-4742182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-47421822016-04-04 Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth Khurana, Ashwani Roy, Debarshi Kalogera, Eleftheria Mondal, Susmita Wen, Xuyang He, Xiaoping Dowdy, Sean Shridhar, Viji Oncotarget Research Paper A promising new strategy for cancer therapy is to target the autophagic pathway. In the current study, we demonstrate that the antimalarial drug Quinacrine (QC) reduces cell viability and promotes chemotherapy-induced cell death in an autophagy-dependent manner more extensively in chemoresistant cells compared to their isogenic chemosensitive control cells as quantified by the Chou-Talalay methodology. Our preliminary data, in vitro and in vivo, indicate that QC induces autophagy by downregulating p62/SQSTM1 to sensitize chemoresistant cells to autophagic- and caspase-mediated cell death in a p53-independent manner. QC promotes autophagosome accumulation and enhances autophagic flux by clearance of p62 in chemoresistant ovarain cancer (OvCa) cell lines to a greater extent compared to their chemosensitive controls. Notably, p62 levels were elevated in chemoresistant OvCa cell lines and knockdown of p62 in these cells resulted in a greater response to QC treatment. Bafilomycin A, an autophagy inhibitor, restored p62 levels and reversed QC-mediated cell death and thus chemosensitization. Importantly, our in vivo data shows that QC alone and in combination with carboplatin suppresses tumor growth and ascites in the highly chemoresistant HeyA8MDR OvCa model compared to carboplatin treatment alone. Collectively, our preclinical data suggest that QC in combination with carboplatin can be an effective treatment for patients with chemoresistant OvCa. Impact Journals LLC 2015-10-16 /pmc/articles/PMC4742182/ /pubmed/26497553 Text en Copyright: © 2015 Khurana et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Khurana, Ashwani Roy, Debarshi Kalogera, Eleftheria Mondal, Susmita Wen, Xuyang He, Xiaoping Dowdy, Sean Shridhar, Viji Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
title | Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
title_full | Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
title_fullStr | Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
title_full_unstemmed | Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
title_short | Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
title_sort | quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742182/ https://www.ncbi.nlm.nih.gov/pubmed/26497553 |
work_keys_str_mv | AT khuranaashwani quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth AT roydebarshi quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth AT kalogeraeleftheria quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth AT mondalsusmita quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth AT wenxuyang quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth AT hexiaoping quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth AT dowdysean quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth AT shridharviji quinacrinepromotesautophagiccelldeathandchemosensitivityinovariancancerandattenuatestumorgrowth |